CNA Diagnostics Inc. has closed a new round of financing, raising $#SUBSCRIBERS ONLY CONTENT – where and how did you get your news? Subscribe today to see our research on this and all other subscriber ONLY news. Be informed!#
Calgary based CNA Diagnostics Inc. (CNAD) is a Molecular Diagnostics company developing disruptive diagnostic tests for a wide spectrum of complex diseases affecting people, pets and production animals. The company plans to commercialize high-sensitivity and specificity, molecular diagnostic technologies for subclinical detection of major diseases of food producing animals, companion animal and humans.
In June 2017, CNA Diagnostics and its German partners Metabion GmbH and Becker & Hickl GmbH were awarded CDN $800,000 from the Alberta and German governments to pursue development of a high throughput, rapid testing diagnostic machine.
photo credit: CNA Diagnostics Inc.
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Bridgit discloses BDC Capital led $6.24M Series A - March 18, 2019
- AEPONYX secures $7.9M Series A led by Pangaea Ventures - March 14, 2019
- BrandProject to raise second fund - March 14, 2019